Australia's largest stock trading and investment forum Australia's #1 stock forum

RHT - This explains the recent buying over the last several days

First 220 Last

Share
Profile

Follow
tskoo

1,086 Posts.

10

19/07/19

11:30

Post #: 39598165
Share

Originally posted by mcexplorer: ↑

RHT

Resonance Health Limited (ASX: RHT) (“Resonance Health” or the “Company”) is pleased to announce that it has executed a Master Services Agreement (“MSA”) and an associated initial Scope of Work with a US NASDAQ-listed pharmaceutical company (the “Client”) for the use of Resonance Health products and services in their clinical trial. The clinical trial covered under the initial Scope of Work will commence in July 2019 and continue for a period of 48 months. This period may be extended, for example if the clinical trial takes longer than expected. As consideration for satisfactorily performing the services in the initial Scope of Work, the Company will be paid approximately US $1 million over the duration of the trial.

Expand

RHT - This explains the recent buying over the last several days
4 Upvote

Reply

Top Stories

RCE

Recce's R327 found effective against E.coli during clinical trial

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

3DP

Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

There are more pages in this discussion • 142 more messages in this thread...

First 220 Last

SPONSORED BY